Search Within

Dana Elizabeth Rathkopf

  1. "Bastien Nguyen"
Formats
  1. Journal Article (3)
  2. Meeting Abstract (1)
Groups
  1. Center for Molecular Imaging and Biotechnology (CMIB) (4)
  2. Computational Oncology Service (4)
  3. Department of Medicine (4)
  4. Epidemiology and Biostatistics (4)
  5. GSK Faculty (4)
  6. Genitourinary Oncology Service (4)

More Groups

People
  1. Bastien Nguyen (4)
  2. David Solit (4)
  3. Howard Scher (4)
  4. Konrad Stopsack (4)
  5. Michael Morris (4)
  6. Nikolaus Schultz (4)

More People

Years
  1. 2022 (1)
  2. 2020 (3)
Publications
  1. Cancer Research (1)
  2. Clinical Cancer Research (1)
  3. European Urology (1)
  4. JCO Precision Oncology (1)
Publishers
  1. American Association for Cancer Research (2)
  2. American Society of Clinical Oncology (1)
  3. Elsevier Science, Inc. (1)

Results (4)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Differences in prostate cancer genomes by self-reported race: Contributions of genetic ancestry, modifiable cancer risk factors, and clinical factors
    Journal Article

    Stopsack, K. H.; Nandakumar, S.; Arora, K.; Nguyen, B.; Vasselman, S. E.; Nweji, B.; McBride, S. M.; Morris, M. J.; Rathkopf, D. E.; Slovin, S. F.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • CDK12 alterations define a distinct molecular subtype of prostate cancers with unique genomic and clinical characteristics
    Meeting Abstract

    Nguyen, B.; Mota, J. M.; Nandakumar, S.; Stopsack, K. H.; Weg, E.; Rathkopf, D.; Morris, M. J.; Scher, H.; Kantoff, P. W.; Gopalan, A.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Pan-cancer analysis of CDK12 alterations identifies a subset of prostate cancers with distinct genomic and clinical characteristics
    Journal Article

    Nguyen, B.; Mota, J. M.; Nandakumar, S.; Stopsack, K. H.; Weg, E.; Rathkopf, D.; Morris, M. J.; Scher, H. I.; Kantoff, P. W.; Gopalan, A.; more...
    European Urology (2020)

    Fulltext@MSK | Save
  • Platinum-based chemotherapy in metastatic prostate cancer with DNA repair gene alterations
    Journal Article

    Mota, J. M.; Barnett, E.; Nauseef, J. T.; Nguyen, B.; Stopsack, K. H.; Wibmer, A.; Flynn, J. R.; Heller, G.; Danila, D. C.; Rathkopf, D.; more...
    JCO Precision Oncology (2020)

    Fulltext@MSK | Save